INTEGRA LIFESCIENCES HOLDINGS CORPORATION (NASDAQ:IART) Files An 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
ITEM 5.03 Amendments to Articles of Incorporation or Bylaws;
Change in Fiscal Year.
Integra LifeSciences Holdings Corporation (the Company), the
stockholders approved an amendment to the Companys Amended and
Restated Certificate of Incorporation,>increasing its
authorized shares of common stock and effecting a two-for-one
stock split. The amendment to the Companys Amended and Restated
Certificate of Incorporation>was filed with the Secretary of
State of the State of Delaware on December 21, 2016 increasing
the Companys authorized common stock from sixty million shares
(60,000,000) to two-hundred and forty million shares
(240,000,000) and effecting the stock split. The Certificate of
Amendment is filed as Exhibit 3.1 to this report.
The final results of the matter submitted to a vote of
stockholders at the Special Meeting is as follows:
Certificate of Incorporation, as amended to increase the number
of authorized shares of common stock of the Company from
60,000,000 to 240,000,000 shares (the Amendment) for the purpose
of, among other things, effecting a proposed two-for-one stock
split of the Companys Common Stock as part of the Amendment.
|
For
|
Against
|
Abstain
|
|
35,516,833
|
456,711
|
4,647
|
announcing a two-for-one stock split. A copy of the Companys
press release is attached hereto as Exhibit 99.1 to this Current
Report on Form 8-K and is incorporated herein by reference.
|
3.1
|
Amendment to the Companys Amended and Restated Certificate
of Incorporation, as amended |
About INTEGRA LIFESCIENCES HOLDINGS CORPORATION (NASDAQ:IART)
Integra LifeSciences Holdings Corporation is a medical technology company. The Company focuses on the development, manufacturing and marketing of surgical implants and medical instruments. Its products are used in neurosurgery, extremity reconstruction, orthopedics and general surgery. Its segments include Specialty Surgical Solutions, which offers products, including specialty surgical instrumentation for a range of specialties. Its product category includes products and solutions for dural repair, precision tools and instruments, tissue ablation and neuro critical care, including product portfolios used in neurosurgery operation suites and critical care units, and Orthopedics and Tissue Technologies, which offers products of a combination of differentiated regenerative technology products for soft tissue repair and tissue regeneration products, and small bone fixation and joint replacement hardware products for both upper extremities and lower extremities. INTEGRA LIFESCIENCES HOLDINGS CORPORATION (NASDAQ:IART) Recent Trading Information
INTEGRA LIFESCIENCES HOLDINGS CORPORATION (NASDAQ:IART) closed its last trading session up +0.57 at 85.91 with 398,314 shares trading hands.
